Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Human Psychopharmacology|October 31, 2002
Quantitative EEG methods and measures in human psychopharmacological researchVerner J Knott
Experimental and Clinical Psychopharmacology|August 21, 2007
Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokersVerner J Knott, Derek J Fisher
Journal of Clinical Psychopharmacology|September 4, 2010
Acute nicotine alteration of sensory memory impairment in smokers with schizophreniaLouise Dulude, Alain Labelle, Verner J Knott
Biological Psychology|September 15, 2010
Auditory hallucinations and the P3a: attention-switching to speech in schizophreniaDerek J Fisher, Alain Labelle, Verner J Knott
Schizophrenia Research|June 26, 2012
Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illnessDerek J Fisher, Alain Labelle, Verner J Knott
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 12, 2008
The right profile: mismatch negativity in schizophrenia with and without auditory hallucinations as measured by a multi-feature paradigmDerek J Fisher, Alain Labelle, Verner J Knott
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|May 31, 2008
Auditory hallucinations and the mismatch negativity: processing speech and non-speech sounds in schizophreniaDerek J Fisher, Alain Labelle, Verner J Knott
Experimental and Clinical Psychopharmacology|December 25, 2002
EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenicsVerner J Knott, Alain LaBelle, Barry Jones, et al.
Neuroimage. Clinical|December 2, 2024
Functional connectivity profiles in remitted depression and their relation to ruminative thinkingZhuo Fang, Emma Lynn, Verner J Knott, et al.
Schizophrenia Research|January 4, 2011
MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patientsJemeen Horton, Anne Millar, Alain Labelle, et al.
Pageof 4